THE ROLE OF THE URETRAL CATHETER IN THE DEVELOPMENT OF CATHETER-RELATED URINARY TRACT INFECTION


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The most common source of nosocomial infection is the urinary tract, especially if they it is drained with a urethral catheter. Catheter-associated urinary tract infections account for at least 80% of all complicated urinary tract infections and are the most common type of hospital-acquired infection. Intestinal microflora plays the leading role in the pathogenesis of catheter-associated urinary tract infections, whereas the most important risk factor for their development is the long duration of urinary catheter drainage. In the case of short-term and intermittent catheterization, routine antibiotic prophylaxis is not required, but if a patient develops clinically significant infection, antibiotic therapy is required followed by definitive therapy based on culture. Urethral catheters coated with antimicrobial substances and anti-inflammatory agents can significantly reduce the adhesion and migration of bacteria, thereby reducing the incidence of urinary tract infections. Despite this, the incidence of catheter-associated infection remains high. We have reviewed recent literature related to catheter-associated urinary tract infections and the best means of preventing this condition.

Full Text

Restricted Access

About the authors

A. O Vasilyev

A.I. Evdokimov Moscow State University of Medicine and Dentistry

Email: alexvasilyev@me.com
PhD, Teaching Assistant at the Department of Urology Moscow, Russia

A. V Govorov

A.I. Evdokimov Moscow State University of Medicine and Dentistry

Email: dr.govorov@gmail.com
Dr.Med.Sci., Associate Professor at the Department of Urology Moscow, Russia

A. A Shiryaev

A.I. Evdokimov Moscow State University of Medicine and Dentistry

Email: eschief2@gmail.com
Department of Urology Resident Moscow, Russia

D. Yu Pushkar’

A.I. Evdokimov Moscow State University of Medicine and Dentistry

Email: pushkardm@mail.ru
corresponding member of RAS Moscow, Russia

References

  1. Eriksen H.M., Iversen B.G., Aavitsland P. Prevalence of nosocomial infections in hospitals in Norway, 2002 and 2003. J Hosp Infect. 2005;60:40-45.
  2. Maki D.G., Tambyah P.A. Engineering out the risk for infection with urinary catheters. Emerg Infect Dis. 2001;7:342-347.
  3. Gould C.V., Umscheid C.A., Agarwal R.K., Kuntz G., Pegues D.A. Infect Control Hosp Epidemiol. Guideline for prevention of catheter-associated urinary tract infections 2009. 2010;31(4):319- 326.
  4. Tenke P., Kovacs B., Bjerklund Johansen T.E., Matsumoto T., Tambyah P.A., Naber K.G. European and Asian guidelines on management and prevention of catheter-associated urinary tract infections. Int J Antimicrob Agents. 2008;31S:68-78.
  5. Mladenovic J., Veljovic M., Udovicic I., Lazic S., Segrt Z., Ristic P. Catheter-associated urinary tract infection in a surgical intensive care unit. Vojnosanit Pregl. 2015;72(10):883-888.
  6. Clec’h C., Schwebel C., Francais A. Does catheter-associated urinary tract infection increase mortality in critically ill patients? Infect Control Hosp Epidemiol. 2007;28:1367-1373.
  7. Tambyah P.A., Oon J. Catheter-associated urinary tract infection. Curr Opin Infect Dis. 2012;25(4):365-370.
  8. Lo E., Nicolle L.E., Coffin S.E. Strategies to prevent catheter-associated urinary tract infections in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol. 2014;35(5):464-479.
  9. Septimus E.J., Moody J. Prevention of Device-Related Healthcare-Associated Infections. Available at https://www.ncbi.nlm.nih.gov/pmc/articles/ PMC4754053/
  10. Trautner B.W., Grigoryan L., Petersen N.J. Effectiveness of an Antimicrobial Stewardship Approach for Urinary Catheter-Associated Asymptomatic Bacteriuria. JAMA Intern Med. 2015;175(7):1120-1127.
  11. Nakano H., Seko S., Sumii T., Nihira H., Fujii M., Okada K. Efficacy of a latex Foley catheter with sustained release of chlorhexidine: 1st report: Clinical trials for prevention of urinary tract infection. Hinyokika Kiyo. 1986;32(4):567-574.
  12. Riley D.K., Classen D.C., Stevens L.E. A large randomized clinical trial of a silver-impregnated urinary catheter: Lack of efficacy and staphylococcal superinfection. Am. J. Med. 1995;98:349-356.
  13. Saint S., Elmore J.G., Sullivan S.D. The efficacy of silver alloy-coated urinary catheters in preventing urinary tract infection: A meta analysis. Am. J. Med. 1998;105:236-241.
  14. Kumon H., Hashimoto H. Catheter-associated urinary tract in- fections: impact of catheter materials on their management. Int. J. Antimicrobiol. Agents. 2001;17:311-316.
  15. Thibon P., Le Coutour X. Randomized multi-centre trial of the effects of a catheter coated with hydrogel and silver salts on the incidence of hospital-acquired urinary infections. J. Hosp. Infect. 2000;45:117-124.
  16. Lawrence E.L., Turner I.G. Materials for urinary catheters: a review of their history and development in the UK. Medical Engineering & Physics. 2005;27:443-453.
  17. Pickard R., Lam T., MacLennan G., Starr K., Kilonzo M., McPherson G., Gillies K., McDonald A., Walton K., Buckley B., Glazener C., Boachie C., Burr J., Norrie J., Vale L., Grant A., N’Dow J.K. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring shortterm catheterisation in hospital: a multicentre randomised controlled trial. Lancet. 2012;1(9857):1927-1935.
  18. Desai D.G., Liao K.S., Cevallos M.E. Silver or nitrofurazone impregnation of urinary catheters has a minimal effect on uropathogen adherence. J Urol. 2010;184(6):2565-2571.
  19. Rani S.A., Celeri C., Najafi R., Bley K., Debabov D. Irrigation with N,Ndichloro-2,2-dimethyltaurine (NVC-422) in a citrate buffer maintains urinarycatheter patency in vitro and prevents encrustation by Proteus mirabilis. Urolithiasis. 2016;44(3):247-256.
  20. Kumar C.G., Sujitha P. Green synthesis of Kocuran-functionalized silver glyconanoparticles for use as antibiofilm coatings on silicone urethral catheters. Nanotechnology. 2014;25(32):325101.
  21. Wang R., Neoh K.G., Kang E.T., Tambyah PA., Chiong E. Antifouling coating with controllable and sustained silver release for long-term inhibition of infection and encrustation in urinary catheters. J Biomed Mater Res B Appl Biomater. 2015;103(3):519-528.
  22. Lam T.B., Omar M.I., Fisher E., Gillies K., MacLennan S. Types of indwelling urethral catheters for short-term catheterisation in hospitalised adults. Cochrane Database Syst Rev. 2014;9:CD004013.
  23. Johnson J.R., Roberts P.L., Olsen R.J., Moyer K.A., Stamm W.E. Prevention of catheter-associated urinary tract infection with a silver oxide-coated urinary catheter: clinical and microbiologic correlates. Journal of Infectious Diseases. 1990;162:1145-1150.
  24. Riley D.K., Classen D.C., Stevens L.E., Burke J.P. A large randomized clinical trial of a silver-impregnated urinary catheter: lack of efficacy and staphylococcal superinfection. American Journal of Medicine. 1995;98(4):349-356.
  25. Takeuchi H., Hida S., Yoshida O., Ueda T. Clinical study on efficacy of a Foley catheter coated with silver-protein in prevention of urinary tract infections. Hinyokika Kiyo. 1993;39(3):293-298.
  26. Karchmer T.B., Giannetta E.T., Muto C.A., Strain B.A., Farr B.M. A randomized crossover study of silver-coated urinary catheters in hospitalized patients. Archives of Internal Medicine. 2000;160(2):3294-3298.
  27. Thibon P., Le Coutour X., Leroyer R., Fabry J. Randomized multi-centre trial of the effects of a catheter coated with hydrogel and silver salts on the incidence of hospital-acquired urinary tract infection. Journal of Hospital Infection. 2000;45(2):117-124.
  28. Stenzelius K., Persson S., Olsson U.B., Stjarneblad M. Noble metal alloy-coated latex versus silicone Foley catheter in short-term catheterization: a randomized controlled study. Scandinavian Journal of Urology and Nephrology. 2011;45(4):258-264.
  29. AlHabdan I., Sadat-Ali M., Corea J.R., Al Othman A., Kamal B.A., Shriyan D.S. Assessment of nosocomial urinary tract infections in orthopaedic patients: a prospective and comparative study using two different catheters. International Surgery. 2003;88(3):152-154.
  30. Stensballe J., Tvede M., Looms D., Lippert F.K., Dahl B, Tonnesen E. Infection risk with nitrofurazone-impregnated urinary catheters in trauma patients: a randomized trial. Annals of Internal Medicine. 2007;147(5):285-293.
  31. Darouiche R.O., Smith J.A., Hanna H., Dhabuwala C.B., Steiner M.S., Babaian R.J. Efficacy of antimicrobial-impregnated bladder catheters in reducing catheter-associated bacteriuria: A prospective, randomised, multicentre clinical trial. Urology. 1999;54(6):976-987.
  32. Wald H., Ma A., Bratzler D., Kramer A. Indwelling urinary catheter use in the postoperative period: analysis of the National Surgical Infection Prevention Project Data. Arch Surg. 2008;143:551-557.
  33. Trautner B. Management of catheter-associated urinary tract infection (CAUTI). NIH Public Access (PA). 2010;23:76-82.
  34. Bonfill X., Rigau D., Jáuregui-Abrisqueta M.L., Barrera Chacon J.M., de la Barrera SS, Alemán-Sánchez CM, et al. A randomized controlled trial to assess the efficacy and cost-effectiveness of urinary catheterswith silver alloy coating in spinal cord injured patients: trial protocol. BMC Urol. 2013;13:38.
  35. Hazan Z., Zumeris J., Jacob H., Raskin H., Kratysh G., Vishnia M., Dror N., Barliya T., Mande M., Lavie G. Effective Prevention of Microbial Biofilm Formation on Medical Devices by Low-Energy Surface Acoustic Waves. Antimicrobial agents and chemotherary. 2006; 50(12):4144-4152.
  36. Kopel M., Degtyar E., Banin E. Surface acoustic waves increase the susceptibility of Pseudomonas aeruginosa biofilms to antibiotic treatment. Biofouling. 2011;27(7):701-710.
  37. Vasilyev A.O., Govorov A.V., Rewa I.A., Schneiderman M.G., Pushkarev V.A., Pushkar D.Y. Alternative approaches to prevention and treatment of postoperative complications by introduction of new models urinary catheter. Urologiia. 2016;6:5-10
  38. Vasilyev A.O., Govorov A.V., Pushkar D.Y. The role of the urethral catheter in the development of a catheter-associated infection. Urologiceskie vedomosti. 2017;7:19-20

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies